✦ LIBER ✦

Bcl-2 Gene Expression as a Predictor of Outcome in Diffuse Large B-Cell Lymphoma

✍ Scribed by Shivakumar, Latha; Armitage, James O.

Book ID: 119935889
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 93 KB
Volume: 6
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2006.n.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diffuse Large B Cell Lymphoma: From Gene

Diffuse Large B Cell Lymphoma: From Gene Expression Profiling to Prediction of Outcome

✍ Izidore S. Lossos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Algorithmic fusion of gene expression pr

Algorithmic fusion of gene expression profiling for diffuse large B-cell lymphoma outcome prediction

✍ Qiuming Zhu; Hongmei Cui; Kajia Cao; Chan, W.C. 📂 Article 📅 2004 🏛 IEEE 🌐 English ⚖ 749 KB

Prognostic significance of bcl-2, bax, a

Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma

✍ Sang Kyun Sohn; Jin Tae Jung; Dong Hwan Kim; Jong Gwang Kim; Eun Kyung Kwak; Tae 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 2 views

Differential Role of BCL2 in Molecular S

Differential Role of BCL2 in Molecular Subtypes of Diffuse Large B-cell Lymphoma

✍ Dunleavy, K.; Wilson, W. H. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 233 KB

Coexistent Rearrangements of c-MYC,BCL2,

Coexistent Rearrangements of c-MYC,BCL2, andBCL6Genes in a Diffuse Large B-Cell Lymphoma

✍ Chiyoko Ueda; Momoko Nishikori; Toshio Kitawaki; Takashi Uchiyama; Hitoshi Ohno 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 346 KB

Pathogenetic and clinical implications o

Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas

✍ Pescarmona, Edoardo; De Sanctis, Vitaliana; Pistilli, Alessandra; Pacchiarotti, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Bcl-6 (LAZ-3) and Bcl-2 gene rearrangements have been respectively reported in 20-35 per cent and 10-25 per cent of diffuse large B-cell lymphomas (DLBCLs). Although these genetic lesions have been associated with different clinical outcomes (i.e., more favourable in Bcl-6 rearranged cases and poore